| Bioactivity | PCSK9-IN-24 (Compound OY3) is a compound that targets PCSK9. PCSK9-IN-24 reduces PCSK9 levels and increases LDL uptake and may be used in atherosclerosis research[1]. |
| Name | PCSK9-IN-24 |
| CAS | 2974496-96-1 |
| Formula | C36H36Br2N4O6S |
| Molar Mass | 812.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ouyang Z, et al. Targeted Degradation of PCSK9 In Vivo by Autophagy-Tethering Compounds. J Med Chem. 2024 Jan 11;67(1):433-449. |
PCSK9-IN-24
CAS: 2974496-96-1 F: C36H36Br2N4O6S W: 812.57
PCSK9-IN-24 (Compound OY3) is a compound that targets PCSK9. PCSK9-IN-24 reduces PCSK9 levels and increases LDL uptake a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.